Home › Companies › 89bio, Inc. › 2024-2025

89bio, Inc. 2024-2025 Proxy Voting Records

Compiled from SEC Form N-PX filings and 89bio, Inc.’s Form 8-K, filed 2025-05-30 (Item 5.07 on EDGAR). Page generated 02 October 2026.

6Reported items
197Asset managers
976Fund votes
2025-05-28Meeting date

Proxy season: 2023-2024 2024-2025

Explore 89bio, Inc. in the interactive database Compare manager voting policies

Official 2024-2025 meeting results reported by 89bio, Inc.

These tallies are 89bio, Inc.’s own, as disclosed to the U.S. Securities and Exchange Commission on Form 8-K, filed 2025-05-30 (Item 5.07, “Submission of Matters to a Vote of Security Holders”). They cover every share voted at the meeting, not just the funds that file Form N-PX.

89bio, Inc. — official shareholder meeting results, meeting held 2025-05-28
Ballot item	For	Against	Abstain	Withheld	Broker non-votes	Outcome
Elect Director: • Martin Babler	104,787,288	--	--	19,874,826	9,430,895	Majority: yes
Elect Director: • Derek DiRocco, Ph.D.	63,538,191	--	--	61,123,923	9,430,895	Majority: yes
Elect Director: • Lota Zoth, C.P.A.	121,166,878	--	--	3,495,236	9,430,895	Majority: yes

Source: 89bio, Inc., Form 8-K, filed with the SEC on 2025-05-30 — read the filing on EDGAR.

How asset managers voted at the 89bio, Inc. 2024-2025 meeting

Each item below shows how the 197 asset managers that disclosed a 89bio, Inc. vote in their SEC Form N-PX filings actually voted. Share totals are the shares those managers' funds voted, summed across every fund they report. These are reported items, not a count of the ballot: fund filings describe one ballot item in different words. Two descriptions are shown as one item only on evidence — the same text (or one cut short of the other), the same director nominee, or a match to the same row of 89bio, Inc.’s own Form 8-K tally — never because they merely read alike. A description that could not be joined that way is listed on its own, so one ballot item can appear more than once.

1. Approval of, on an advisory basis, the compensation of the Company's named executive officers.

SECTION 14A SAY-ON-PAY VOTES

Combines 3 wordings of this item as funds reported it.

94% fund support · no official result

FOR 94%

The 188 asset managers below cast 94% of the shares they voted on this item FOR (126,671,299 for, 8,286,523 against).

FOR: 126,671,299 (93.9%)AGAINST: 8,286,523 (6.1%)NOT VOTED: 5,360 (0.0%)

Largest asset managers voting on “Approval of, on an advisory basis, the compensation of the Company's named executive officers.” at 89bio, Inc., 2024-2025
Asset manager	For	Against	Vote
Janus Henderson	19,856,189	0	For
SUVRETTA CAPITAL MANAGEMENT, LLC	14,436,376	0	For
RA CAPITAL MANAGEMENT, L.P.	12,342,692	0	For
Deep Track Capital, LP	9,345,578	0	For
BlackRock	8,837,684	5,389	For
Vanguard	7,247,337	0	For
JANUS INVESTMENT FUND	6,488,879	0	For
State Street	5,558,645	965	For
Avoro Capital Advisors LLC	4,348,989	0	For
PICTET ASSET MANAGEMENT SA	3,900,314	0	For
Fidelity	3,873,709	0	For
WESTFIELD CAPITAL MANAGEMENT CO LP	3,265,851	42,530	For
GEODE CAPITAL MANAGEMENT, LLC	2,829,208	0	For
Logos Global Management LP	0	2,750,000	Against
Charles Schwab	2,012,605	0	For
HARBOR FUNDS	1,970,323	0	For
RTW INVESTMENTS, LP	1,967,527	0	For
Redmile Group, LLC	0	1,804,211	Against
Citadel	1,637,064	0	For
SILVERARC CAPITAL MANAGEMENT, LLC	1,177,600	0	For
EMERALD MUTUAL FUND ADVISERS TRUST	1,082,973	0	For
Northern Trust	1,028,018	0	For
Nuveen	916,411	0	For
TIAA	905,254	0	For
Rock Springs Capital Management LP	841,434	0	For

Showing the 25 largest of 188 asset managers. See all 188 in the interactive database.

2. Election of Directors: To be elected for terms expiring in 2028: Derek DiRocco, Ph.D.

DIRECTOR ELECTIONSMajority of the votes cast: yes

Combines 6 wordings of this item as funds reported it.

51.0% Majority: yes · of votes cast

FOR 51.0%WITHHELD 49.0%

FOR: 63,538,191WITHHELD: 61,123,923

89bio, Inc.’s own tally for this item (“Elect Director: • Derek DiRocco, Ph.D.”): 63,538,191 for, 61,123,923 withheld, per its Form 8-K filed 2025-05-30 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 145,984,182 outstanding shares: 44% for, 42% withheld (85% of the company cast a for/withheld vote).

The 60 asset managers below cast 100% of the shares they voted on this item FOR (12,742,895 for, 0 against).

FOR 40%ABSTAIN 60%

FOR: 12,742,895 (40.1%)ABSTAIN: 19,061,654 (59.9%)

Largest asset managers voting on “Election of Directors: To be elected for terms expiring in 2028: Derek DiRocco, Ph.D.” at 89bio, Inc., 2024-2025
Asset manager	For	Abstain	Vote
Vanguard	7,001,364	0	For
JANUS INVESTMENT FUND	0	6,488,879	Abstain
BlackRock	0	4,718,482	Abstain
Fidelity	3,160,206	47,095	For
HARBOR FUNDS	0	1,970,323	Abstain
State Street	4,184	1,758,549	Abstain
Charles Schwab	1,006,302	0	For
TIAA	905,254	0	For
Erste Asset Management GmbH	0	883,000	Abstain
FINANCIAL INVESTORS TRUST	0	512,471	Abstain
Principal	0	355,665	Abstain
Equitable	0	333,760	Abstain
Harbor Funds II	314,772	0	For
Royce	226,000	0	For
RBB FUND, INC.	0	214,837	Abstain
Dimensional	0	204,286	Abstain
American Century	0	184,648	Abstain
Goldman Sachs	0	182,930	Abstain
Lord Abbett	0	166,323	Abstain
Morgan Stanley	0	114,764	Abstain
Northern Trust	0	88,434	Abstain
Lincoln Financial	0	81,800	Abstain
Direxion Shares ETF Trust	0	73,308	Abstain
Global X	0	66,466	Abstain
ProShares	0	59,723	Abstain

Showing the 25 largest of 60 asset managers. See all 60 in the interactive database.

3. Election of Directors: To be elected for terms expiring in 2028: Lota Zoth, C.P.A.

DIRECTOR ELECTIONSMajority of the votes cast: yes

Combines 5 wordings of this item as funds reported it.

97% Majority: yes · of votes cast

FOR 97%

FOR: 121,166,878WITHHELD: 3,495,236

89bio, Inc.’s own tally for this item (“Elect Director: • Lota Zoth, C.P.A.”): 121,166,878 for, 3,495,236 withheld, per its Form 8-K filed 2025-05-30 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 145,984,182 outstanding shares: 83% for, 2% withheld (85% of the company cast a for/withheld vote).

The 60 asset managers below cast 100% of the shares they voted on this item FOR (30,498,769 for, 0 against).

FOR 96%

FOR: 30,498,769 (95.9%)ABSTAIN: 1,305,780 (4.1%)

Largest asset managers voting on “Election of Directors: To be elected for terms expiring in 2028: Lota Zoth, C.P.A.” at 89bio, Inc., 2024-2025
Asset manager	For	Abstain	Vote
Vanguard	7,001,364	0	For
JANUS INVESTMENT FUND	6,488,879	0	For
BlackRock	4,718,482	0	For
Fidelity	3,207,301	0	For
HARBOR FUNDS	1,970,323	0	For
State Street	1,762,733	0	For
Charles Schwab	1,006,302	0	For
TIAA	905,254	0	For
Erste Asset Management GmbH	883,000	0	For
FINANCIAL INVESTORS TRUST	0	512,471	Abstain
Principal	0	355,665	Abstain
Equitable	326,820	6,940	For
Harbor Funds II	314,772	0	For
Royce	226,000	0	For
RBB FUND, INC.	0	214,837	Abstain
Dimensional	0	204,286	Abstain
American Century	184,648	0	For
Goldman Sachs	182,930	0	For
Lord Abbett	166,323	0	For
Morgan Stanley	114,764	0	For
Northern Trust	88,434	0	For
Lincoln Financial	81,800	0	For
Direxion Shares ETF Trust	73,308	0	For
Global X	66,466	0	For
ProShares	59,723	0	For

Showing the 25 largest of 60 asset managers. See all 60 in the interactive database.

4. Election of Directors: To be elected for terms expiring in 2028: Martin Babler

DIRECTOR ELECTIONSMajority of the votes cast: yes

Combines 5 wordings of this item as funds reported it.

84% Majority: yes · of votes cast

FOR 84%WITHHELD 16%

FOR: 104,787,288WITHHELD: 19,874,826

89bio, Inc.’s own tally for this item (“Elect Director: • Martin Babler”): 104,787,288 for, 19,874,826 withheld, per its Form 8-K filed 2025-05-30 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 145,984,182 outstanding shares: 72% for, 14% withheld (85% of the company cast a for/withheld vote).

The 60 asset managers below cast 100% of the shares they voted on this item FOR (24,221,486 for, 0 against).

FOR 76%ABSTAIN 24%

FOR: 24,221,486 (76.2%)ABSTAIN: 7,583,063 (23.8%)

Largest asset managers voting on “Election of Directors: To be elected for terms expiring in 2028: Martin Babler” at 89bio, Inc., 2024-2025
Asset manager	For	Abstain	Vote
Vanguard	7,001,364	0	For
JANUS INVESTMENT FUND	6,488,879	0	For
BlackRock	0	4,718,482	Abstain
Fidelity	3,160,206	47,095	For
HARBOR FUNDS	1,970,323	0	For
State Street	1,762,666	67	For
Charles Schwab	0	1,006,302	Abstain
TIAA	905,254	0	For
Erste Asset Management GmbH	883,000	0	For
FINANCIAL INVESTORS TRUST	0	512,471	Abstain
Principal	0	355,665	Abstain
Equitable	136,621	197,139	Abstain
Harbor Funds II	314,772	0	For
Royce	226,000	0	For
RBB FUND, INC.	0	214,837	Abstain
Dimensional	0	204,286	Abstain
American Century	184,648	0	For
Goldman Sachs	182,930	0	For
Lord Abbett	166,323	0	For
Morgan Stanley	114,764	0	For
Northern Trust	88,434	0	For
Lincoln Financial	81,800	0	For
Direxion Shares ETF Trust	73,308	0	For
Global X	0	66,466	Abstain
ProShares	59,723	0	For

Showing the 25 largest of 60 asset managers. See all 60 in the interactive database.

5. RATIFICATION OF THE APPOINTMENT OF KPMG LLP AS OUR INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR THE YEAR ENDING DECEMBER 31, 2025.

AUDIT-RELATED

100% fund support · no official result

FOR 100%

The 59 asset managers below cast 100% of the shares they voted on this item FOR (30,921,549 for, 0 against).

FOR: 30,921,549 (100.0%)

Largest asset managers voting on “RATIFICATION OF THE APPOINTMENT OF KPMG LLP AS OUR INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR THE YEAR ” at 89bio, Inc., 2024-2025
Asset manager	For	Vote
Vanguard	7,001,364	For
JANUS INVESTMENT FUND	6,488,879	For
BlackRock	4,718,482	For
Fidelity	3,207,301	For
HARBOR FUNDS	1,970,323	For
State Street	1,762,733	For
Charles Schwab	1,006,302	For
TIAA	905,254	For
FINANCIAL INVESTORS TRUST	512,471	For
Principal	355,665	For
Equitable	333,760	For
Harbor Funds II	314,772	For
Royce	226,000	For
RBB FUND, INC.	214,837	For
Dimensional	204,286	For
American Century	184,648	For
Goldman Sachs	182,930	For
Lord Abbett	166,323	For
Morgan Stanley	114,764	For
Northern Trust	88,434	For
Lincoln Financial	81,800	For
Direxion Shares ETF Trust	73,308	For
Global X	66,466	For
ProShares	59,723	For
Pacific Life	55,229	For

Showing the 25 largest of 59 asset managers. See all 59 in the interactive database.

6. Advisory Vote to Ratify Named Executive Officers' Compensation

SECTION 14A SAY-ON-PAY VOTES

96% fund support · no official result

FOR 96%

The 6 asset managers below cast 96% of the shares they voted on this item FOR (1,181,263 for, 45,457 against).

FOR: 1,181,263 (96.3%)AGAINST: 45,457 (3.7%)

Largest asset managers voting on “Advisory Vote to Ratify Named Executive Officers' Compensation” at 89bio, Inc., 2024-2025
Asset manager	For	Against	Vote
Erste Asset Management GmbH	883,000	0	For
Eversept Partners, LP	245,298	0	For
JPMorgan	52,921	0	For
ALGERT GLOBAL LLC	0	43,170	Against
Desjardins Global Asset Management Inc.	0	2,287	Against
Coyle Financial Counsel LLC	44	0	For

Largest 89bio, Inc. shareholders voting in 2024-2025

Ranked by the number of 89bio, Inc. shares each manager voted on the most widely held ballot item of the 2024-2025 meeting, shown as a share of the 145,984,182 shares outstanding at the time of that meeting.

Top 89bio, Inc. shareholders by shares voted, 2024-2025
#	Asset manager	% of shares outstanding
1	Janus Henderson	13.60%
2	SUVRETTA CAPITAL MANAGEMENT, LLC	9.89%
3	RA CAPITAL MANAGEMENT, L.P.	8.45%
4	Deep Track Capital, LP	6.40%
5	BlackRock	6.06%
6	Vanguard	4.96%
7	JANUS INVESTMENT FUND	4.44%
8	State Street	3.81%
9	Avoro Capital Advisors LLC	2.98%
10	PICTET ASSET MANAGEMENT SA	2.67%

Reported 89bio, Inc. ownership

Positions disclosed to the SEC on Schedules 13D and 13G, Form 13F and the company’s own proxy statement (DEF 14A).

89bio, Inc. beneficial owners on record for the 2024-2025 proxy season
Holder	% outstanding	Disclosure
Entities affiliated with Janus Henderson Group plc	13.88%	DEF14A
Entities affiliated with RA Capital	13.71%	DEF14A
Entities affiliated with Suvretta Capital Management, LLC	6.99%	DEF14A
BlackRock	6.90%	13F
Entities affiliated with RTW Investments, LP	5.05%	DEF14A
Vanguard Group	4.91%	13F
JANUS HENDERSON GROUP PLC	3.68%	13G
Citadel Advisors	3.55%	13F
BVF PARTNERS L P/IL	2.97%	13G
State Street	2.76%	13F

Percentages above are of 145,984,182 shares outstanding, as reported by 89bio, Inc. on its Form 10-Q dated 2025-03-31 (see the filing on EDGAR). This is the count contemporaneous with the 2024-2025 meeting, so the percentages are the ones that were true then, not ones restated against today’s share count.

About this page

Every figure above is derived from filings made with the US Securities and Exchange Commission: Form N-PX, in which registered investment companies and institutional managers disclose how they voted every proxy, and Form 8-K Item 5.07, in which the company reports its own meeting results. Shares outstanding are taken from 89bio, Inc.’s 10-Q dated 2025-03-31. This page is a static snapshot rebuilt weekly on 02 October 2026; a live search always shows the current data.

At 89bio, Inc.'s shareholder meeting held 2025-05-28, in the 2024-2025 proxy season, 197 asset managers reported how they voted in their SEC Form N-PX filings, covering 976 separate fund positions. Their filings are grouped here into 6 reported items; because filers word the same ballot item differently, that can be more than the number of items on the ballot. 89bio, Inc.'s own Form 8-K tally for this meeting is published below, but no row in it could be matched to the most widely held item, so this page states no certified outcome for that item. On that item — Approval of, on an advisory basis, the compensation of the Company's named executive officers. — the reporting funds cast 94% of the shares they voted in favour (FOR divided by FOR plus AGAINST, the conventional basis for proxy support; abstentions, broker non-votes and unvoted shares are excluded because none of them took a side). That is the aggregate of those managers' own N-PX disclosures, not the company's certified result, and the funds are a subset of all shareholders.

89bio, Inc. proxy season coverage: 2023-2024 · 2024-2025 (this page).